Rebecca Pyle

Rebecca Pyle is an accomplished clinical operations professional with extensive experience in the biotechnology and pharmaceutical industries. As of September 2023, Rebecca serves as the Executive Director of Clinical Operations at Merus N.V. Previously, Rebecca held senior roles at CRISPR Therapeutics, including Senior Director and Director of Clinical Operations, and worked at Takeda and Shire as Director and Associate Director in Clinical Operations, respectively. Further experience includes positions at Gilead Sciences, Ventrus Biosciences, Quintiles, and Exelixis, where Rebecca developed expertise in clinical program management and trial operations. Rebecca holds a Bachelor of Arts in Biochemistry and Molecular Biology from Gustavus Adolphus College and a Master of Arts in Molecular Genetics from Washington University in St. Louis.